maprotiline has been researched along with Dementia in 1 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchs, A | 1 |
| Hehnke, U | 1 |
| Erhart, C | 1 |
| Schell, C | 1 |
| Pramshohler, B | 1 |
| Danninger, B | 1 |
| Schautzer, F | 1 |
1 trial available for maprotiline and Dementia
| Article | Year |
|---|---|
Video rating analysis of effect of maprotiline in patients with dementia and depression.
Topics: Aged; Aged, 80 and over; Dementia; Depressive Disorder; Double-Blind Method; Female; Humans; Male; M | 1993 |